Robert Wasserman is an Equity Research Analyst covering Bioprocessing and Life Sciences companies. Prior to Benchmark, Bob’s 25-plus years of investment experience includes previous equity research positions at Craig-Hallum, Dawson James, Southeast Research Partners, and Jesup & Lamont. He was named an All-Star Analyst in Healthcare by the Wall Street Journal and has been quoted and appeared in financial print and media outlets. Bob holds BS degrees in engineering and management from MIT and an MBA from the University of Chicago.
